Israel-based MeMed Diagnostics Ltd, a diagnostic solutions provider for prevention of antibiotic misuse, has raised over $70 million from investors including China’s Ping An Global Voyager Fund, according to a company release.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
